Clinical Trials Logo

Clinical Trial Summary

One of the most common causes of loss of smell is upper respiratory tract infection. These disorders can be quantitative (hyposmia or anosmia) or qualitative (parosmia or phantosmia). Loss of smell has been found as a major and frequent clinical sign of Sars Cov2 infection (more than 50% of patients screened at the CHU Nancy). Spontaneous recovery remains possible. It usually occurs in the first month . But when symptoms persist, the therapeutic management of post-viral anosmias is poorly codified in the literature. Olfactory rehabilitation could allow faster recovery and better quality, but the published protocols are numerous and could only be tested on small inhomogeneous series of patients (mixture of post-viral and post-traumatic hypo-ansomy). The significant increase in the population of patients suffering from post-viral anosmia following the current pandemic situation makes it possible to consider a prospective study aiming to compare two olfactory rehabilitation protocols: "classic" and "intensive" in a population of patients. suffering only from post-viral hypoanosmia. Hypothesis: Intensive or classic olfactory rehabilitation allows better results than spontaneous recovery


Clinical Trial Description

80 patients will be recruited from among the patients consulting the otorhinolaryngology department of the Nancy CHRU for the assessment of viral post-infectious olfactory disorders. The inclusion visit will be carried out during a standard routine care consultation with the following: - an endoscopic endonasal examination - the olfactory assessment (evaluation of smell by self-assessment, Dynachron-olfaction questionnaire, olfactory test by Sniffin 'Stick) At the end of this assessment and after having received the information on the study and signed the consent form, the patients confirmed to be hypo-anosmic will then be randomized into 2 groups: - "classic" olfactory rehabilitation group - "intensive" olfactory rehabilitation group The rehabilitation kits (8 jars or 4 jars depending on the randomization group) will be provided to the patient with therapeutic education in their use. The patient will carry out olfactory rehabilitation (intensive or classic) at home twice a day (morning and evening) for 32 weeks (i.e. 448 sessions). The patient will smell each odor for 10 seconds with an interval of 10 seconds between odors. Each training will be recorded by the patient in his olfactory rehabilitation agenda. The patient will go again for a follow-up consultation for the renewal of his olfactory assessment at 4 months (follow-up visit 1) and at 8 months (follow-up visit 2) post-inclusion as part of the routine care of disorders of the smell post virus infection. In addition to the olfactory assessment during these visits, the investigator will also verify that the rehabilitation schedule is being kept. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04598763
Study type Interventional
Source Central Hospital, Nancy, France
Contact Julie Lecomte
Phone +33 3 83 15 52 78
Email ju.lecomte@chru-nancy.fr
Status Recruiting
Phase N/A
Start date July 1, 2020
Completion date January 1, 2021

See also
  Status Clinical Trial Phase
Completed NCT04526054 - Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients N/A
Recruiting NCT04799977 - COVID-19: Post-covid Olfactory Disorders Assessment
Completed NCT04529161 - Olfactory and Taste Changes During Fasting Mimicking Diet (FMD) N/A
Completed NCT00660868 - Is Pentoxifylline Able to Improve Olfactory Sensitivity? N/A
Completed NCT04361474 - Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity Phase 3
Withdrawn NCT01814618 - Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery Phase 2
Completed NCT03698760 - Computerized Olfactory Test - Alzheimer Disease Mild Stage N/A
Completed NCT04406584 - Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction N/A
Completed NCT02565121 - Olfaction Disorders in Patients Included in The Trauma Brain Injury (TBI) Database at Trondheim University Hospital N/A
Recruiting NCT05364125 - Olfactory Training on Smell Dysfunction Patients in HK N/A
Withdrawn NCT04696601 - Rapid Screening for Olfactory Disorders in Covid-19 Infection N/A
Terminated NCT04104594 - Olfaction and Inflammation in Chronic Rhinosinusitis With Nasal Polyps N/A
Withdrawn NCT03043144 - Taste And Smell TEsting in End Stage Renal Disease N/A
Recruiting NCT06204432 - Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction Phase 2
Recruiting NCT04390646 - GnRH Therapy on Cognition in Down Syndrome Phase 2/Phase 3
Enrolling by invitation NCT05666492 - "Platelet Rich Plasma for the Management of Post-Viral Olfactory Dysfunction. N/A